Holly K. Vance was named General Counsel of Neoleukin Therapeutics on October 22, 2020, according to Yahoo Finance.
| Name | Holly K. Vance |
|---|---|
| Role | General Counsel |
| Company | Neoleukin Therapeutics |
| Move | Appointment |
| Date | October 22, 2020 |
| Source | Yahoo Finance |
Who is the general counsel of Neoleukin Therapeutics?
Holly K. Vance took the General Counsel role at Neoleukin Therapeutics in October 2020, as reported by Yahoo Finance. Legal leadership changes often, so check Neoleukin Therapeutics’s own leadership page for the latest. If you know of a newer move, tell us and we will update the directory.
More legal leadership moves at Neoleukin Therapeutics
- Donna Cochener Named General Counsel of Neoleukin Therapeutics (April 5, 2022)
Other general counsel moves in October 2020
- Johnna Spera Named General Counsel of Metropolitan Washington Airports Authority (October 28, 2020)
- Gayle Littleton Named General Counsel of Exelon (October 28, 2020)
- Kristen Shaheen Named General Counsel of BenchPrep (October 27, 2020)
- Julia Johnson Named General Counsel of ICM Partners (October 27, 2020)
- Joshua M. Atlas Named General Counsel of Kaufman Lynn Construction (October 27, 2020)
- Kevin Smith Named General Counsel of JAGGAER (October 26, 2020)
- Bruce A. Johnson Named General Counsel of DispatchHealth (October 22, 2020)
- Alice Geene Named General Counsel of Paycor (October 22, 2020)
Planning your own next move?
- General Counsel and Chief Legal Officer jobs
- Deputy General Counsel jobs
- Open legal jobs at Neoleukin Therapeutics on GoInhouse
Read our guide to becoming a general counsel and the in-house counsel salaries guide.
Browse every appointment in the General Counsel Directory.
Source: Yahoo Finance. InhouseBlog summarizes publicly reported general counsel moves and links to the original report.